Richard B. Womer
About
Richard B. Womer is a scholar working on Pulmonary and Respiratory Medicine, Surgery and Oncology.
According to data from OpenAlex, Richard B. Womer has authored 111 papers receiving a total of 6.1k indexed citations (citations by other indexed papers that have themselves been cited), including 75 papers in Pulmonary and Respiratory Medicine, 37 papers in Surgery and 26 papers in Oncology. Recurrent topics in Richard B. Womer's work include Sarcoma Diagnosis and Treatment (75 papers), Neuroblastoma Research and Treatments (19 papers) and Testicular diseases and treatments (16 papers). Richard B. Womer is often cited by papers focused on Sarcoma Diagnosis and Treatment (75 papers), Neuroblastoma Research and Treatments (19 papers) and Testicular diseases and treatments (16 papers). Richard B. Womer collaborates with scholars based in United States, Canada and Switzerland. Richard B. Womer's co-authors include Naomi Balamuth, Mark Krailo, Holcombe E. Grier, John H. Healey, John P. Dormans, Jeffrey H. Silber, Frederic G. Barr, Yuelin Li, Paul S. Dickman and Paul A. Meyers and has published in prestigious journals such as New England Journal of Medicine, Proceedings of the National Academy of Sciences and Journal of Biological Chemistry.
In The Last Decade
Richard B. Womer
111 papers receiving 5.9k citations
Hit Papers
Peers — A (Enhanced Table)
Peers by citation overlap · career bar shows stage (early→late) cites · hero ref
| Name | h | Career | Trend | Papers | Cites | |||||
|---|---|---|---|---|---|---|---|---|---|---|
| Richard B. Womer United States | 39 | 3.8k | 1.6k | 1.4k | 1.2k | 1.2k | 111 | 6.1k | ||
| Leonard H. Wexler United States | 48 | 4.2k 1.1× | 2.2k 1.4× | 1.4k 1.1× | 1.3k 1.1× | 1.3k 1.1× | 159 | 7.6k | ||
| A. Zoubek Austria | 35 | 4.7k 1.2× | 1.6k 1.0× | 994 0.7× | 1.6k 1.4× | 1.6k 1.3× | 101 | 6.6k | ||
| Daniel Orbach France | 41 | 3.4k 0.9× | 1.8k 1.2× | 1.5k 1.1× | 1.2k 1.0× | 1.3k 1.1× | 317 | 6.3k | ||
| Uta Dirksen Germany | 38 | 3.6k 0.9× | 1.5k 1.0× | 938 0.7× | 1.5k 1.2× | 685 0.6× | 190 | 5.8k | ||
| H. Jürgens Germany | 40 | 3.4k 0.9× | 1.1k 0.7× | 1.0k 0.8× | 851 0.7× | 1.2k 1.0× | 138 | 5.4k | ||
| Michael Paulussen Germany | 34 | 4.6k 1.2× | 1.2k 0.8× | 1.3k 0.9× | 705 0.6× | 1.5k 1.2× | 86 | 5.8k | ||
| Allen M. Goorin United States | 37 | 3.4k 0.9× | 2.0k 1.3× | 626 0.5× | 1.1k 0.9× | 1.2k 1.0× | 56 | 6.2k | ||
| Alessandra Longhi Italy | 47 | 5.4k 1.4× | 2.0k 1.3× | 821 0.6× | 1.5k 1.2× | 2.9k 2.4× | 174 | 7.4k | ||
| Catherine A. Billups United States | 48 | 2.5k 0.6× | 1.8k 1.1× | 868 0.6× | 2.0k 1.6× | 643 0.5× | 165 | 6.0k | ||
| P.A. Voûte Netherlands | 44 | 2.8k 0.7× | 1.4k 0.9× | 1.0k 0.8× | 2.4k 2.0× | 777 0.6× | 106 | 7.1k |
Countries citing papers authored by Richard B. Womer
Since
Specialization
Citations
This map shows the geographic impact of Richard B. Womer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Richard B. Womer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Richard B. Womer more than expected).
Fields of papers citing papers by Richard B. Womer
Since
Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences
This network shows the impact of papers produced by Richard B. Womer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Richard B. Womer. The network helps show where Richard B. Womer may publish in the future.
Co-authorship network of co-authors of Richard B. Womer
This figure shows the co-authorship network connecting the top 25 collaborators of Richard B. Womer. A scholar is included among the top collaborators of Richard B. Womer based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Richard B. Womer. Richard B. Womer is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
1.
Cash, Thomas F., Mark Krailo, Allen Buxton, et al.. (2023). Long-Term Outcomes in Patients With Localized Ewing Sarcoma Treated With Interval-Compressed Chemotherapy on Children's Oncology Group Study AEWS0031. Journal of Clinical Oncology. 41(30). 4724–4728.
2.
Hingorani, Pooja, Mark Krailo, Allen Buxton, et al.. (2022). Phase 2 study of anti-disialoganglioside antibody, dinutuximab, in combination with GM-CSF in patients with recurrent osteosarcoma: A report from the Children's Oncology Group. European Journal of Cancer. 172. 264–275.
3.
Sailer, Scott L., Meenakshi Devidas, Elizabeth J. Perlman, et al.. (2021). Ewing Sarcoma/Primitive Neuroectodermal Tumor of the Chest Wall: Impact of Initial Versus Delayed Resection on Tumor Margins, Survival, and Use of Radiation Therapy. UNC Libraries.
4.
Adamson, Peter C., Gareth J. Veal, Richard B. Womer, et al.. (2019). Fundamental problems with pediatric adaptive dosing of carboplatin using nuclear‐medicine‐based estimates of renal function. Pediatric Blood & Cancer. 66(6). e27672–e27672.
5.
Kadhim, Muayad, Richard B. Womer, & John P. Dormans. (2017). Surgical treatment of pelvic sarcoma in children: outcomes for twenty six patients. International Orthopaedics. 41(10). 2149–2159.
6.
Vo, Kieuhoa T., C. Lorrie Epling, Elizabeth Sinclair, et al.. (2016). Impact of Two Measures of Micrometastatic Disease on Clinical Outcomes in Patients with Newly Diagnosed Ewing Sarcoma: A Report from the Children's Oncology Group. Clinical Cancer Research. 22(14). 3643–3650.
7.
Dirksen, Uta, Marie‐Cécile Le Deley, Bernadette Brennan, et al.. (2016). Efficacy of busulfan-melphalan high dose chemotherapy consolidation (BuMel) compared to conventional chemotherapy combined with lung irradiation in ewing sarcoma (ES) with primary lung metastases: Results of EURO-EWING 99-R2pulm randomized trial (EE99R2pul).. Journal of Clinical Oncology. 34(15_suppl). 11001–11001.
8.
Mascarenhas, Leo, Judy Felgenhauer, Mason Bond, et al.. (2015). Pilot Study of Adding Vincristine, Topotecan, and Cyclophosphamide to Interval-Compressed Chemotherapy in Newly Diagnosed Patients With Localized Ewing Sarcoma: A Report From the Children's Oncology Group. Pediatric Blood & Cancer. 63(3). 493–498.
9.
Weiss, Aaron R., Elizabeth Lyden, James R. Anderson, et al.. (2013). Histologic and Clinical Characteristics Can Guide Staging Evaluations for Children and Adolescents With Rhabdomyosarcoma: A Report From the Children's Oncology Group Soft Tissue Sarcoma Committee. Journal of Clinical Oncology. 31(26). 3226–3232.
10.
Womer, Richard B., Daniel C. West, Mark Krailo, et al.. (2012). Randomized Controlled Trial of Interval-Compressed Chemotherapy for the Treatment of Localized Ewing Sarcoma: A Report From the Children's Oncology Group. Journal of Clinical Oncology. 30(33). 4148–4154.
11.
Ji, Lingyun, Hiroyuki Shimada, Michele R. Wing, et al.. (2010). Current Treatment Protocols Have Eliminated the Prognostic Advantage of Type 1 Fusions in Ewing Sarcoma: A Report From the Children's Oncology Group. Journal of Clinical Oncology. 28(12). 1989–1994.
12.
Granowetter, Linda, Richard B. Womer, Meenakshi Devidas, et al.. (2009). Dose-Intensified Compared With Standard Chemotherapy for Nonmetastatic Ewing Sarcoma Family of Tumors: A Children's Oncology Group Study. Journal of Clinical Oncology. 27(15). 2536–2541.
13.
Meyers, Paul A., Cindy L. Schwartz, Mark Krailo, et al.. (2008). Osteosarcoma: The Addition of Muramyl Tripeptide to Chemotherapy Improves Overall Survival—A Report From the Children's Oncology Group. Journal of Clinical Oncology. 26(4). 633–638.
14.
Shamberger, Robert C., Michael P. LaQuaglia, Mark C. Gebhardt, et al.. (2003). Ewing Sarcoma/Primitive Neuroectodermal Tumor of the Chest Wall. Annals of Surgery. 238(4). 563–568.
15.
Baker, K. Scott, James R. Anderson, Thom E. Lobe, et al.. (2002). Children From Ethnic Minorities Have Benefited Equally as Other Children From Contemporary Therapy for Rhabdomyosarcoma: A Report From the Intergroup Rhabdomyosarcoma Study Group. Journal of Clinical Oncology. 20(22). 4428–4433.
16.
Dormans, John P., David A. Spiegel, James S. Meyer, et al.. (2001). Fibromatoses in childhood: The desmoid/fibromatosis complex*. Medical and Pediatric Oncology. 37(2). 126–131.
17.
Womer, Richard B.. (1997). Soft tissue sarcomas. European Journal of Cancer. 33(13). 2230–2234.
18.
Kelly, Kara M., Richard B. Womer, & Frederic G. Barr. (1996). Minimal disease detection in patients with alveolar rhabdomyosarcoma using a reverse transcriptase‐polymerase chain reaction method. Cancer. 78(6). 1320–1327.
19.
Malik, Rajesh, Richard B. Womer, Thandavarayan Nagashunmugam, et al.. (1991). Structure and expression of the beta-platelet-derived growth factor receptor gene in human tumor cell lines.. PubMed. 51(20). 5626–31.
20.
Womer, Richard B., Jon Pritchard, & T M Barratt. (1985). Renal toxicity of cisplatin in children. The Journal of Pediatrics. 106(4). 659–663.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.
Explore authors with similar magnitude of impact
Breakdown of academic impact, for papers by Leonard H. Wexler Breakdown of academic impact, for papers by A. Zoubek Breakdown of academic impact, for papers by Daniel Orbach Breakdown of academic impact, for papers by Uta Dirksen Breakdown of academic impact, for papers by H. Jürgens Breakdown of academic impact, for papers by Michael Paulussen Breakdown of academic impact, for papers by Allen M. Goorin Breakdown of academic impact, for papers by Alessandra Longhi Breakdown of academic impact, for papers by Catherine A. Billups Breakdown of academic impact, for papers by P.A. Voûte